Address: Kiev, bulv. Shevchenko, 33 B, 5th floor ,Ukraine
Tel: +38 (044) 498-13-34
Web: http://www.mili.ua/
Mili Healthcare Ltd. Great Britain is present in the Ukrainian pharmaceutical market since 2002.
The company’s products gained popularity among Ukrainian consumers based on their high quality, accessible form and detailed information support. In support of the success of the representation of Miles Healthcare Ltd. UK in Ukraine, the company was awarded during the annual awards competition of the national pharmaceutical industry – the Panatsea.
Panatsea-2004 – ‘The most effective debut in the pharmaceutical market of Ukraine.’
Panatsea-2005 – ‘For the strategy of active promotion of drugs.’
In 2006, Milistan medicine won the nationwide contest ‘Favorites of Success.’
The medicine portfolio of Mili Healthcare Ltd. in Ukraine consists of drugs that are widely used in therapy, gastroenterology, otolaryngology practice, gynecology, pediatrics, surgery, critical care, oncology, rheumatology, and pulmonology.
It has been almost a decade since Mili Healthcare began its operations in Ukraine today becoming one of the top 20 leading foreign companies in the local industry. What were…
Igor Bondarenko of Ukraine’s Dnipro State Medical University, Evgeny Levenko from clinical trials company, ARENSIA, and Olena Popova from IQVIA offer their perspectives on maintaining quality and ensuring participant protection…
The March edition of DIA’s Global Forum magazine features a special section on clinical research in Ukraine, over one year on from the beginning of the Russian invasion. Here, Chieko…
The March edition of DIA’s Global Forum magazine features a special section on clinical research in Ukraine, over one year on from the beginning of the Russian invasion. Anina Adelfio…
Russia’s invasion of Ukraine has been roundly condemned by the pharmaceutical industry and almost all Big Pharmas have pledged humanitarian support to Ukraine. However, not all companies have followed the…
Ukraine’s bold decision to outsource public procurement of medicines to international agencies to combat rampant corruption has been well received by the pharma MNCs operational in the country, but faces…
Vladimir Sayenko, founding partner, and Anzhela Makhinova, counsel, of the leading Ukrainian law firm Sayenko Kharenko, give an overview on the Ukrainian pharmaceutical industry in 2017 and explain the expansion…
Tetiana Korotchenko, Country Representative of Crown Agents, one of the three international organizations contracted by the Ukrainian government to temporarily handle healthcare procurement and put an end to the plague…
Dmytro Popov, the owner, founder and CEO Elfa Group, Ukraine’s leading cosmetics manufacturer, provides his insight into Elfa’s 20-year presence in the Ukrainian market, the company’s international growth strategies and…
Dr. Maxim Sokolov, chief external specialist of the Ministry of Health of Ukraine in cardiology, principal scientist of the Department of Interventional Cardiology of the National Academy of Medical Sciences…
Dr. Paul Melekhov, vice president Eastern Europe at Pharmascience, Canada’s third largest generic company, provides insights into the unique history of Pharmascience in Ukraine and the pioneering market approach that…
Julia Sidorova, country manager of Alvogen, a new international player to the Ukrainian market, provides insights into the targeted strategy that Alvogen employs throughout the world and how this is…
Victoria Filatova, president and chairperson of the Association of Perfumery and Cosmetics of Ukraine (APCU), discusses her strategic priorities, the association’s main achievements in its six years of existence, and…
See our Cookie Privacy Policy Here
